Journal
CANCER LETTERS
Volume 347, Issue 2, Pages 159-166Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2014.03.013
Keywords
Biomarker; Cancer; Chemotherapy; Lab approach; Mechanism; Multi-drug resistance (MDR)
Categories
Funding
- National Basic Research Program of China [2010CB732400, 2010CB529300]
- National Natural Science Foundation of China [81172062, 81030044]
Ask authors/readers for more resources
Multi-drug resistance (MDR) has become the largest obstacle to the success of cancer chemotherapies. The mechanisms of MDR and the approaches to test MDR have been discovered, yet not fully understood. This review covers the in vivo and in vitro approaches for the detection of MDR in the laboratory and the mechanisms of MDR in cancers. This study also envisages the future developments toward the clinical and therapeutic applications of MDR in cancer treatment. Future therapeutics for cancer treatment will likely combine the existing therapies with drugs originated from MDR mechanisms such as anti-cancer stem cell drugs, anti-miRNA drugs or anti-epigenetic drugs. The challenges for the clinical detection of MDR will be to find new biomarkers and to determine new evaluation systems before the drug resistance emerges. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available